Group One Trading
ANIK icon

Group One Trading’s Anika Therapeutics ANIK Stock Holding History

Group One Trading’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45K Sell
3,100
-400
-11% -$4.64K ﹤0.01% 5343
2025
Q4 		$33.6K Buy
3,500
+3,200
+1,067% +$30.6K ﹤0.01% 5923
2025
Q3 		$2.82K Buy
300
+100
+50% +$955 ﹤0.01% 7789
2025
Q2 		$2.12K Buy
+200
New +$2.52K ﹤0.01% 7403
2025
Q1 		– Sell
-100
Closed -$1.65K – 7535
2024
Q4 		$1.65K Buy
+100
New +$1.97K ﹤0.01% 6785
2024
Q2 		– Sell
-12,500
Closed -$318K – 6661
2024
Q1 		$318K Buy
+12,500
New +$302K ﹤0.01% 3168
2023
Q3 		– Sell
-300
Closed -$7.79K – 7602
2023
Q2 		$7.79K Sell
300
-300
-50% -$8.03K ﹤0.01% 6515
2023
Q1 		$17.2K Buy
+600
New +$17.9K ﹤0.01% 5604
2021
Q2 		– Sell
-75,000
Closed -$3.06M – 8101
2021
Q1 		$3.06M Sell
75,000
-300
-0.4% -$11.4K ﹤0.01% 2015
2020
Q4 		$3.41M Buy
75,300
+46,900
+165% +$1.78M 0.01% 1599
2020
Q3 		$1M Buy
28,400
+22,600
+390% +$816K ﹤0.01% 2186
2020
Q2 		$219K Buy
5,800
+100
+2% +$3.29K ﹤0.01% 3298
2020
Q1 		$165K Buy
+5,700
New +$231K ﹤0.01% 2902
2019
Q3 		– Sell
-9,100
Closed -$370K – 5104
2019
Q2 		$370K Buy
9,100
+3,300
+57% +$120K ﹤0.01% 2409
2019
Q1 		$175K Buy
+5,800
New +$199K ﹤0.01% 2796
2018
Q4 		– Sell
-5,700
Closed -$240K – 4828
2018
Q3 		$240K Sell
5,700
-3,000
-34% -$119K ﹤0.01% 2886
2018
Q2 		$278K Buy
+8,700
New +$358K ﹤0.01% 2780
2017
Q4 		– Sell
-1,100
Closed -$64K – 4804
2017
Q3 		$64K Sell
1,100
-1,900
-63% -$99.3K ﹤0.01% 3493
2017
Q2 		$148K Buy
3,000
+2,100
+233% +$96.7K ﹤0.01% 2857
2017
Q1 		$39K Buy
+900
New +$43K ﹤0.01% 3550
2013
Q3 		– Sell
-3,100
Closed -$53K – 5162
2013
Q2 		$53K Buy
+3,100
New +$44.7K ﹤0.01% 3376

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Group One Trading's ANIK Position: Q1 2020 in Review

Group One Trading sold out of Anika Therapeutics (ANIK) in Q1 2020, closing a stake of 5,196 shares — an estimated $210K sold.

Group One Trading first reported a position in ANIK in Q4 2013 and held it in 17 quarters. The position peaked at $503K in Q2 2015. 164 funds tracked by Wall St. Rank hold ANIK as of Q1 2020.

  • Group One Trading reported no remaining Anika Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Group One Trading sold 5,196 Anika Therapeutics shares in Q1 2020, an estimated $210K.
  • Group One Trading first reported a position in Anika Therapeutics in Q4 2013 and held it in 17 quarters.
  • Group One Trading's Anika Therapeutics position peaked at $503K in Q2 2015.
  • 164 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2020.

Based on Group One Trading's 13F filing for Q1 2020, filed 13 May 2020.